I gave my nuanced opinion about #sglt2i in an interview for Nature.
https://www.nature.com/articles/d41586-023-00648-3
#flozination #ChronicKidneyDisease
#diabetes
#SGLT2i #flozination #ChronicKidneyDisease #diabetes
RT @GiuseppeGalati_
🔥 New potential role of the liver in #erythropoietin syntesis by #SGLT2i
💡 A new hypothesis by M.Packer via HIF-2a stimulation
👇Here the potential mechanisms involved
@gcfmd @DrMarthaGulati @iamritu @gbiondizoccai @JBauersachsMD @ehj_ed @mvaduganathan
RT @SABOURETCardio
#Baxdrostat is now owned by AstraZeneca : a future combination with a #SGLT2i ?
RT @SABOURETCardio
waiting for #pubmed. #T2D #SGLT2i for all ? #Cardiotwitter https://twitter.com/ArchMedSci/status/1621639268991909888
#pubmed #T2D #SGLT2i #cardiotwitter
RT @SABOURETCardio
New anti-diabetic agents: major advances with unanswered questions. #GLP1RA #SGLT2i #T2D https://pubmed.ncbi.nlm.nih.gov/33387991/
RT @SABOURETCardio
Comparing benefits from #SGLT2i and #GLP1RA #MA https://pubmed.ncbi.nlm.nih.gov/35195376/
There will likely be a generic #flozin in the US next year. There are already generic #flozins #sglt2i available in many countries that do not even have the costs used in this simulation, and thus the results don't apply to them. So, while the calculations are likely to become irrelevant in the US very soon, the paper will be used to restrict access to these drugs through formularies in many locales.
https://jamanetwork.com/journals/jamacardiology/fullarticle/2802216?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=030523#.ZATGQTbUGiE.twitter
They are too old/not proteinuric enough/have not optimized their RASi (the latter after being on 2.5mg of lisinopril for 5 years) so they can't get #flozin , #SGLT2i , #finerenone etc for their (diabetic) kidney disease
RT @SABOURETCardio
#T2D #SGLT2i #GLP1RA #guidelines https://twitter.com/archmedsci/status/1621639268991909888
#T2D #SGLT2i #glp1ra #guidelines
Sick day rules and #Flozins
Detailed contrarian review and good discussion of #SGLT2i use during hospitalization https://pubmed.ncbi.nlm.nih.gov/35801339/ (gated)
Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing
@ChristosArgyrop & @mike_johansen for thoughts?
See their algorithm:
RT @GiuseppeGalati_
#Top3 RCTs of #2022
🥇🏆#DELIVER : #SGLT2i Class I in #HFpEF & #HFmrEF (full spectrum of #LVEF)
🥈#STRONG_HF: High-Intensity (fast #GDMT start in #HFrEF better than step delayed approach)
🥉#REVIVED_PCI : Still too large use of #PCI in ischemic #HFrEF (need for more RCTs)
@gcfmd
#top3 #deliver #SGLT2i #hfpef #hfmref #lvef #strong_hf #GDMT #hfref #revived_pci #PCI
Thanks to all who attended. Follow the link to revisit our #cardiology #bootcamp
#PhysicianAssociate #NursePractitioner #sglt2i #nsMRA #resistantHTN @APAC_Cardiology @brianrosePAS @Lross246 @leyadiel @GiaconaJohn https://www.instagram.com/p/CmwmurbLYUM/?igshid=MDJmNzVkMjY=
#cardiology #bootcamp #physicianassociate #NursePractitioner #SGLT2i #nsmra #resistanthtn
RT @mvaduganathan
A Welcome ‘Failure’ of Gliflozins: #BloodPressure Reduction in #HeartFailure in @escardio #EHJ
@Kieranfdocherty & @PSJhund highlight the relative hemodynamical neutrality of #SGLT2i in HF, facilitating their ease of use.
Average BP ↓ of just <2-3mmHg!
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehac712/6895825
#BloodPressure #heartfailure #ehj #SGLT2i
This is one of the graphs that justify doing a clinical trial of a #SGLT2I ie #flozin (or a #DRA , Direct Renin Antagonist) + #MRA (Mineralocorticoid Antagonist) in post #covid19 states with persistent detection of the spike antigen in the blood. If the spike is detectable, then it screws up ratios of Ang1-9,Ang1-7 to AngII ➡️? cardiovascular disease post covid.
#sarscov2
@Nephron post on twitter as the source of this graph
https://twitter.com/nephronus/status/1601831332094644225?t=ygKLhDAoDS_vvGx6UV9qyA&s=19
#SGLT2i #flozin #dra #mra #COVID19 #SarsCoV2
RT @ACCinTouch
A 74 y/o 👴 w/ #HFpEF (EF 60%), #hypertension, & #CKD on hemodialysis presents for 🏥 follow-up. He was recently admitted for #heartfailure.
❓ Your patient should not be considered for a #SGLT2i at this time.
A. Fact
B. Fiction
Comment 👇 & learn more: https://bit.ly/3XGpynQ
#hfpef #hypertension #CKD #heartfailure #SGLT2i
Patients with albuminuric #CKD without diabetes that are treated with #RAASi and #SGLT2i may experience ~7 additional years free of kidney failure and death.
https://cjasn.asnjournals.org/content/early/2022/11/20/CJN.08900722
Great Idea by @cilib
Here are my hashtags
#kidney
#CKD #ESRD #dialysis
#transplantation
#nephrology
#sarcopenia #frailty #rehabilitation
#immunosuppression
#transplantID
#DiabeticNephropathy #SGLT2i #Flozinator
#organspende #OrganspendeRettetLeben #organspendeausweis
#Xenotransplantation
#DRG #fckDRG
#humanismus #humanrights #progress #dualismus #dualism
#kidney #CKD #ESRD #dialysis #transplantation #Nephrology #sarcopenia #frailty #rehabilitation #immunosuppression #transplantID #DiabeticNephropathy #SGLT2i #Flozinator #organspende #OrganspendeRettetLeben #organspendeausweis #Xenotransplantation #DRG #fckDRG #humanismus #humanrights #progress #Dualismus #dualism